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Objectives The objective of our study was to examine age-specific mortality rates from coronary heart disease (CHD), partic-
ularly those among younger adults.
Background Trends for obesity, diabetes, blood pressure, and metabolic syndrome among young adults raise concerns about
the mortality rates from CHD in this group.
Methods We used mortality data from 1980 to 2002 to calculate age-specific mortality rates from CHD for U.S. adults
age 35 years.
Results Overall, the age-adjusted mortality rate decreased by 52% in men and 49% in women. Among women age
35 to 54 years, the estimated annual percentage change (EAPC) in mortality was 5.4% (95% confidence
interval [CI] 5.8 to 4.9) from 1980 until 1989, 1.2% (95% CI 1.6 to 0.8) from 1989 until 2000,
and 1.5% (95% CI 3.4 to 6.6) from 2000 until 2002. Among men age 35 to 54 years, the EAPC in mortal-
ity was 6.2% (95% CI 6.4 to 5.9) from 1980 until 1989, 2.3% (95% CI 2.6 to 2.1) from 1989
until 2000, and 0.5% (95% CI 3.7 to 2.9) from 2000 until 2002. Among women and men age 55
years, the estimated annual percentage decrease in mortality from CHD accelerated in more recent years
compared with earlier periods.
Conclusions The mortality rates for CHD among younger adults may serve as a sentinel event. Unfavorable trends in several
risk factors for CHD provide a likely explanation for the observed mortality rates. (J Am Coll Cardiol 2007;50:
2128–32) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.05.056a
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Cn the U.S., mortality rates from coronary heart disease
CHD) have continued to decline steadily since 1968 (1).
evertheless, CHD remains the leading cause of death and
xacts a heavy social and economic toll. Improvements in
opulation risk factors and in medical treatments of patients
ith CHD both contributed substantially to the declines
een between 1980 and 1990 (2).
See page 2133
Concern had been expressed that the rate of decline in the
ge-adjusted mortality rate from CHD has slowed during the
990s compared with the earlier decade (3). The trends in the
ge-adjusted mortality rate may conceal differences in the
rends in the age-specific rates, which have received little
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ontrol and Prevention.t
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007, accepted May 14, 2007.ttention. The particularly unfavorable trends in several risk
actors for CHD among young adults raises the possibility that
he trends in the mortality rates from CHD among younger
dults declined less than those in older ones (4–9). Therefore,
ur objective was to examine the trends in the age-specific rates
or CHD among U.S. adults from 1980 to 2002, particularly
mong younger adults.
ethods
ital statistics data from the U.S. were used (10). We limited
ur analyses to people age 35 years or older. The underlying
ause of death from CHD was determined using the Interna-
ional Classification of Diseases (ICD)-9 codes 410-414 and
29.2 for 1980 to 1998 and ICD-10 codes I20-I25 for 1999 to
002. Population counts from the U.S. Census were used to
alculate rates. We used census counts for the years 1980, 1990,
nd 2000 and intercensal estimates for the other years. Age
djustment was performed using the direct method to the
stimated U.S. population of the year 2000 (11).
We used the software Joinpoint, version 3.0 (National
ancer Institute, Bethesda, Maryland), to examine changes inhe annual percentage change in mortality rates from CHD
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November 27, 2007:2128–32 CHD Mortality Trends12). This software uses a Monte Carlo permutation test to
dentify points where the direction or magnitude of the trend
hanges and then fits the simplest model containing the fewest
umber of trend segments. We specified a maximum number
f 3 joinpoints and assumed a Poisson distribution. For each
egment, the software calculates the estimated annual percent-
ge change (EAPC) and its 95% confidence interval (CI). In
ddition, the software tests whether the slope of each trend
egment differs significantly from the segment immediately
receding it by using a t test.
esults
he overall age-adjusted mortality rate declined from 1980
hrough 2002 by 52% in men and by 49% in women (Fig. 1).
he average annual rate of decline for men was 2.9% during
he 1980s, decreasing to 2.6% during the 1990s, and for
omen, it was 2.6% decreasing to 2.4%. From 2000 through
002, the average annual rate of decline was 4.4% for both men
nd women.
The age-adjusted rates concealed striking differences in
he trends in age-specific rates (Tables 1 and 2, Fig. 2).
hen the overall time period was split into 2, the robust
ecrease in mortality rates that was observed for both men
nd women age 35 to 54 years during the period from 1980
o 1990 decelerated significantly for both genders during the
eriod from 1991 to 2002. For those age 55 years,
owever, the rate of decrease was larger in the later period
han the earlier one for both genders.
To provide a more nuanced examination of the data in each
ender and age group, changes in the trend during the 23-year
eriod were detected by Joinpoint regression modeling.
mong women age 35 to 54 years, mortality decreased
ignificantly by 5.4% from 1980 to 1989, slowed to an annual
ate of decrease of 1.2%, and turned positive between 2000 and
Figure 1 Trends in Age-Adjusted Mortality
Rates From Coronary Heart Disease
Among both U.S. men and women age 35 years, the age-adjusted mortality
rates from coronary heart disease have decreased steadily from 1980 through
2002.002, albeit with a wide CI that included 0%. Among men age C5 to 54 years, the mortality rate
ecreased by 6.2% per year from
980 to 1989, slowed to 2.3% per
ear from 1989 to 2000, and lev-
led off between 2000 and 2002.
mong women age55 years, the
APC was 1.5% between 1980
nd 1999 and accelerated to
4.8% from 1999 until 2002.
mong men age 55 years, the
APC was 2.6% between 1980
nd 1990, slowed to 1.9% from 1990 to 1996, and accelerated
o 3.7% from 1996 until 2002.
iscussion
he trends for mortality from CHD among U.S. adults age 35
o 54 years are disquieting. The EAPC slowed markedly from
980 to 2002 in both men and women. Particularly notewor-
hy is that the mortality rate among women age 35 to 44 years
as been increasing on average by 1.3% (95% CI 0.2 to 2.5) per
ear since 1997.
Changes in mortality rates generally reflect changes in
ncidence and case-fatality rate (13). Unfortunately, solid
ata about incidence of CHD in the U.S. are not readily
vailable. Many studies use hospitalization rates as a rather
nsatisfactory proxy that can be difficult to interpret (14).
hus, data from the Worcester Heart study and Olmsted
ounty both reported decreases in incidence from the late
970s into the late 1980s (15,16). Data from the Nurses’
ealth study from 1980 to 1994 also reported a reduction in
he incidence of CHD among participants age 34 to 59
ears (17). Conversely, an analysis of data from the Ath-
rosclerosis Risk in Communities study reported an increase
n the incidence of hospitalizations for myocardial infarction
etween 1987 and 1994 among residents age 35 to 74 years
18). A subsequent analysis of the data from this same study
howed a decrease in the hospitalization rate of non–ST-
egment elevation acute coronary syndrome between 1987
nd 1994 (19). Among women living in Olmsted County,
he incidence of CHD appeared to have increased during
he early 1990s (16). An analysis of data from the National
ealth and Nutrition Examination Survey I Epidemiologic
APC in Unadjusted Mortality Rates From Coronaryeart Disease Among U.S. Adults Age >35 Years,980 to 2002
Table 1
EAPC in Unadjusted Mortality Rates From Coronary
Heart Disease Among U.S. Adults Age >35 Years,
1980 to 2002
1980 to 1990 1991 to 2002
EAPC 95% CI EAPC 95% CI
Age 35–54 yrs
Men 6.0 6.2 to5.8 2.1 2.4 to1.8
Women 5.2 5.5 to5.0 0.9 1.4 to0.5
Age 55 yrs
Men 2.6 2.7 to2.4 2.9 3.3 to2.5
Women 1.5 1.7 to1.3 2.3 2.7 to1.8
Abbreviations
and Acronyms
CHD  coronary heart
disease
CI  confidence interval
EAPC  estimated annual
percentage change
ICD  International
Classification of DiseasesI  confidence interval; EAPC  estimated annual percentage change.
E*EAPC is significantly different from slope in antecedent period (p  0.05).
Abbreviations as in Table 1.
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CHD Mortality Trends November 27, 2007:2128–32Figure 2 Trends in Age-Specific Mortality Rates From Coronary Heart Disease
Among adults age 35 to 44 years, the mortality rate from coronary heart disease changed little among women (squares) since the late 1980s and showed evidence of leveling off in
more recent years among men (triangles). Among adults age 45 to 54 years, the rate of decline in the mortality rate from coronary heart disease slowed around 1990 in both
men and women.APC in Age-Specific Mortality Rates From Coronary Heart Disease Among U.S. Adults Age >35 Years, 1980 to 2002
Table 2 EAPC in Age-Specific Mortality Rates From Coronary Heart Disease Among U.S. Adults Age >35 Years, 1980 to 2002
Period 1 Period 2 Period 3
Gender and Age (yrs) Years EAPC (95% CI) Years EAPC (95% CI) Years EAPC (95% CI)
Men
35–54 1980 to 1989 6.2 (6.4 to5.9) 1989 to 2000 2.3* (2.6 to2.1) 2000 to 2002 0.5 (3.7 to 2.9)
55 1980 to 1990 2.6 (2.8 to2.4) 1990 to 1996 1.9* (2.5 to1.3) 1996 to 2002 3.7* (4.2 to3.3)
Women
35–54 1980 to 1989 5.4 (5.8 to4.9) 1989 to 2000 1.2* (1.6 to0.8) 2000 to 2002 1.5 (3.4 to 6.6)
55 1980 to 1999 1.5 (1.6 to1.4) 1999 to 2002 4.8* (6.6 to3.0)
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November 27, 2007:2128–32 CHD Mortality Trendsollow-up study suggested that both reductions in incidence
nd case-fatality rates contributed to the decline in cardiovas-
ular disease between 1971 and 1992, as in other industrialized
ountries (20). Data from the Framingham Heart study
howed declines in mortality from sudden cardiac death and
onsudden CHD between 1950 and 1999, suggesting that
oth primary and secondary prevention contributed to the
eclines (21). Reductions in the case-fatality rate for CHD
ave been reported consistently (15,16,18,19,22–25).
Unfortunately, data concerning the incidence and case-
atality rates of CHD among young adults are not readily
vailable. However, the unfavorable trends during the 1990s in
ortality rates from CHD among young adults coincided with
substantial deterioration in several risk factors for CHD.
onsiderable increases in abdominal obesity, diabetes, and
ypertension in younger adults (4,5,8,9) have been com-
ounded by stasis in cholesterol concentrations (6,7).
The increases in the prevalence of obesity and diabetes in the
.S. since 1976 to 1980 (26–28) and the increases in the
revalence of the metabolic syndrome and hypertension during
he 1990s (5,8) are potential warning signs that the hard-
ought gains in mortality improvements might be arrested or
ven reversed. In addition, the decline in concentrations of
otal cholesterol slowed during the 1990s, even as the use of
holesterol-lowering medications escalated (6,7). However, the
revalence of smoking continues to decline (29), and a slight
ecrease in the proportion of U.S. adults who are totally
edentary during leisure time has also occurred during the late
990s (30). As a result of the conflicting trends in the various
isk factors, the risk of CHD as determined by the National
holesterol Education Program risk score for CHD has not
hanged (31).
The adverse mortality trends in young adults have occurred
espite the increasingly wide use of evidence-based therapies
uch as angioplasty, thrombolysis, angiotensin-converting en-
yme inhibitors, statins, and antiplatelet agents. This suggests
hat a vigorous public health response is needed to address
ifestyle behaviors. Efforts to accelerate the past declines in
moking must be continued. Increased efforts to improve diet
re now urgently required (32,33). Policy change at the
ational and state levels potentially offers the most effective and
ost-effective interventions (33,34). To prevent obesity, energy
ntake must be less than energy expenditure. For many,
essages of caloric restriction and increased physical activity,
herefore, need to be amplified. Clinicians should also be aware
f the unfavorable trends in coronary heart disease among
ounger adults in recent years and vigorously screen for risk
actors for cardiovascular disease as recommended by guide-
ines and provide counsel about appropriate lifestyle behaviors.
or patients found to have 1 or more risk factors, clinicians
hould optimally manage these risk factors according to pre-
ailing guidelines.
Timely actions could potentially transform the abhorrent risk
actor profile that currently characterizes much of the U.S. pop-
lation and counteract the adverse trends that are now killing
ounger adults. Complacency runs a high risk: mortality rates
1mong younger adults may represent the leading edge of a
rewing storm.
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APPENDIX
or the annual percent changes in mortality rates from CHD among U.S.
dults age >35 years by gender and age group, please see the online
ersion of this article.
